We are live on ! Find out more
WST icon

West Pharmaceutical
WST

294 hedge funds and large institutions have $5.45B invested in West Pharmaceutical in 2017 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 114 increasing their positions, 97 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

52% more call options, than puts

Call options by funds: $351K | Put options by funds: $231K

42% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 31

18% more repeat investments, than reductions

Existing positions increased: 114 | Existing positions reduced: 97

2% more funds holding

Funds holding: 287 → 294 (+7)

0.69% less ownership

Funds ownership: 91.68% → 90.99% (-0.69%)

4% less capital invested

Capital invested by funds: $5.69B → $5.45B (-$244M)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

Holders
294
Holders Change
+7
Holders Change %
+2.44%
% of All Funds
7.32%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
44
Increased
114
Reduced
97
Closed
31
Calls
$351K
Puts
$231K
Net Calls
+$120K
Net Calls Change
+$2.83M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$480M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$32.8M
3
Wells Fargo
Wells Fargo
California
+$22M
4
Select Equity Group
Select Equity Group
New York
+$16M
5
JP Morgan Chase
JP Morgan Chase
New York
+$15.6M

Top Sellers

Rank Fund Capital Flow
1
KI
Kalmar Investments
Delaware
-$48.3M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$43.1M
3
GIM
Granahan Investment Management
Massachusetts
-$26.7M
4
RCG
Ruane, Cunniff & Goldfarb
New York
-$26.3M
5
BAMCO Inc
BAMCO Inc
New York
-$19.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
LTFS
226
Ladenburg Thalmann Financial Services
Florida
$245K +$3.26K +39 +1%
CI
227
Cigna Investments
Connecticut
$236K +$17.9K +214 +8%
PAG
228
Private Advisor Group
New Jersey
$232K +$7.61K +91 +3%
Zurich Cantonal Bank
229
Zurich Cantonal Bank
Switzerland
$228K +$42.2K +505 +22%
JIM
230
Jupiter Investment Management
United Kingdom
$228K +$234K +2,800 New
PM
231
Parametrica Management
Hong Kong
$227K -$334K -3,999 -59%
KI
232
Koch Industries
Kansas
$225K +$230K +2,752 New
QI
233
QS Investors
New York
$221K +$226K +2,700 +45,000%
Janney Montgomery Scott
234
Janney Montgomery Scott
Pennsylvania
$220K -$16.7K -200 -7%
MLM
235
Mount Lucas Management
Pennsylvania
$213K -$28.7K -343 -12%
FA
236
FDx Advisors
Illinois
$213K +$218K +2,606 New
JMPWA
237
JP Morgan Private Wealth Advisors
California
$212K +$217K +2,590 New
NIT
238
NumerixS Investment Technologies
British Columbia, Canada
$212K +$217K +2,600 New
Squarepoint
239
Squarepoint
New York
$211K -$262K -3,133 -55%
Cambridge Investment Research Advisors
240
Cambridge Investment Research Advisors
Iowa
$210K +$3.35K +40 +2%
Brown Advisory
241
Brown Advisory
Maryland
$203K +$208K +2,489 New
TAM
242
Tyers Asset Management
Texas
$201K +$30.8K +368 +18%
CSS
243
Cubist Systematic Strategies
Connecticut
$197K +$202K +2,420 New
SIM
244
Sonora Investment Management
Arizona
$186K – – –
HA
245
Harfst & Associates
Wyoming
$186K +$191K +2,288 New
CIM
246
Contravisory Investment Management
Massachusetts
$173K – – –
Fifth Third Bancorp
247
Fifth Third Bancorp
Ohio
$163K – – –
BWA
248
Burt Wealth Advisors
Maryland
$158K +$161K +1,927 +38,540%
RCM
249
Riverhead Capital Management
Delaware
$139K +$16.7K +200 +13%
GWM
250
Geneos Wealth Management
Colorado
$129K – – –
8 9
10
11 12

WST Hedge Fund Activity: Q1 2017 in Review

294 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q1 2017, worth a combined $5.45B — down 4.3% from $5.69B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new WST positions and 31 closed out — a net gain of 13 holders — while 114 added to existing stakes and 97 trimmed.

The largest buyer was BlackRock, adding an estimated $480M. The largest seller was Kalmar Investments, cutting an estimated $48.3M.

  • 294 institutional investors held West Pharmaceutical (WST) as of Q1 2017, up from 287 in Q4 2016.
  • Funds reported $5.45B of West Pharmaceutical stock for Q1 2017, down 4.3% quarter-over-quarter.
  • 44 funds opened new West Pharmaceutical positions in Q1 2017 and 31 closed out, a net change of +13 holders.
  • The largest West Pharmaceutical buyer in Q1 2017 was BlackRock, an estimated $480M added.
  • The largest West Pharmaceutical seller in Q1 2017 was Kalmar Investments, an estimated $48.3M sold.

Based on aggregated 13F filings for Q1 2017.